Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2014, Article ID 923903, 8 pages
http://dx.doi.org/10.1155/2014/923903
Research Article

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size

1The Medicines Company (Schweiz) GmbH, Talstrasse 59, 8002 Zürich, Switzerland
2Pacific Biomarkers LLC, 645 Elliott Avenue West, Suite 300, Seattle, WA 98119, USA
3Lipid Metabolism Laboratory, Tufts University, 711 Washington Street, Boston, MA 02111, USA
4Liposcience LLC, 2500 Sumner Boulevard, Raleigh, NC 27616, USA
5Vascular Strategies LLC, 5110 Campus Drive, Suite 150, Plymouth Meeting, PA 19462, USA

Received 30 August 2014; Revised 20 October 2014; Accepted 21 October 2014; Published 12 November 2014

Academic Editor: Akihiro Inazu

Copyright © 2014 Herman J. Kempen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Herman J. Kempen, Dorota B. Schranz, Bela F. Asztalos, et al., “Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size,” Journal of Lipids, vol. 2014, Article ID 923903, 8 pages, 2014. https://doi.org/10.1155/2014/923903.